Cargando…
The cytochrome P450 inhibitor, ketoconazole, inhibits oxidized linoleic acid metabolite-mediated peripheral inflammatory pain
BACKGROUND: Oxidized linoleic acid metabolites (OLAMs) are a class of endogenous agonists to the transient receptor potential V1 (TRPV1) receptor. Although TRPV1 mediates inflammatory heat hyperalgesia, it is not known if the OLAMs contribute to the peripheral activation of this receptor during tiss...
Autores principales: | Ruparel, Shivani, Green, Dustin, Chen, Paul, Hargreaves, Kenneth M |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3488501/ https://www.ncbi.nlm.nih.gov/pubmed/23006841 http://dx.doi.org/10.1186/1744-8069-8-73 |
Ejemplares similares
-
Effect of Ketoconazole, a Cytochrome P450 Inhibitor, on the Efficacy of Quinine and Halofantrine against Schistosoma mansoni in Mice
por: Seif el-Din, Sayed Hassan, et al.
Publicado: (2013) -
Two-way pharmacokinetic interaction studies between saxagliptin and cytochrome P450 substrates or inhibitors: simvastatin, diltiazem extended-release, and ketoconazole
por: Patel, Chirag G, et al.
Publicado: (2011) -
Central activation of TRPV1 and TRPA1 by novel endogenous agonists contributes to mechanical and thermal allodynia after burn injury
por: Green, Dustin P, et al.
Publicado: (2016) -
Cytochrome P450-soluble epoxide hydrolase derived linoleic acid oxylipins and cognitive performance in type 2 diabetes
por: Anita, Natasha Z., et al.
Publicado: (2023) -
Released lipids regulate Transient Receptor Potential Channel (TRP)-dependent oral cancer pain
por: Ruparel, Shivani, et al.
Publicado: (2015)